| Product Code: ETC7913453 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia continued to see steady growth in its import shipments of insulin drugs and devices, with Lithuania, Netherlands, Switzerland, Poland, and Germany being the top exporting countries. Despite the diverse range of sources, the market remains relatively unconcentrated, as indicated by the low Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was a healthy 8.6%, with a notable growth rate of 7.03% from 2023 to 2024, reflecting a promising outlook for the industry in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Insulin Drugs & Devices Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Insulin Drugs & Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Insulin Drugs & Devices Market - Industry Life Cycle |
3.4 Latvia Insulin Drugs & Devices Market - Porter's Five Forces |
3.5 Latvia Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Drugs, 2022 & 2032F |
3.6 Latvia Insulin Drugs & Devices Market Revenues & Volume Share, By Combination drugs, 2022 & 2032F |
3.7 Latvia Insulin Drugs & Devices Market Revenues & Volume Share, By Non-Insulin Injectable drugs, 2022 & 2032F |
3.8 Latvia Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Device, 2022 & 2032F |
4 Latvia Insulin Drugs & Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latvia Insulin Drugs & Devices Market Trends |
6 Latvia Insulin Drugs & Devices Market, By Types |
6.1 Latvia Insulin Drugs & Devices Market, By Insulin Drugs |
6.1.1 Overview and Analysis |
6.1.2 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Drugs, 2022 - 2032F |
6.1.3 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Basal or Long Acting Insulins, 2022 - 2032F |
6.1.4 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Bolus or Fast Acting Insulins, 2022 - 2032F |
6.1.5 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Traditional Human Insulins, 2022 - 2032F |
6.1.6 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Biosimilar Insulins, 2022 - 2032F |
6.2 Latvia Insulin Drugs & Devices Market, By Combination drugs |
6.2.1 Overview and Analysis |
6.2.2 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Insulin combinations, 2022 - 2032F |
6.2.3 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Oral Combinations, 2022 - 2032F |
6.3 Latvia Insulin Drugs & Devices Market, By Non-Insulin Injectable drugs |
6.3.1 Overview and Analysis |
6.3.2 Latvia Insulin Drugs & Devices Market Revenues & Volume, By GLP-1 receptor agonists, 2022 - 2032F |
6.3.3 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Amylin Analogue, 2022 - 2032F |
6.4 Latvia Insulin Drugs & Devices Market, By Insulin Device |
6.4.1 Overview and Analysis |
6.4.2 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pumps, 2022 - 2032F |
6.4.3 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pens, 2022 - 2032F |
6.4.4 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Syringes, 2022 - 2032F |
6.4.5 Latvia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Jet Injectors, 2022 - 2032F |
7 Latvia Insulin Drugs & Devices Market Import-Export Trade Statistics |
7.1 Latvia Insulin Drugs & Devices Market Export to Major Countries |
7.2 Latvia Insulin Drugs & Devices Market Imports from Major Countries |
8 Latvia Insulin Drugs & Devices Market Key Performance Indicators |
9 Latvia Insulin Drugs & Devices Market - Opportunity Assessment |
9.1 Latvia Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Drugs, 2022 & 2032F |
9.2 Latvia Insulin Drugs & Devices Market Opportunity Assessment, By Combination drugs, 2022 & 2032F |
9.3 Latvia Insulin Drugs & Devices Market Opportunity Assessment, By Non-Insulin Injectable drugs, 2022 & 2032F |
9.4 Latvia Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Device, 2022 & 2032F |
10 Latvia Insulin Drugs & Devices Market - Competitive Landscape |
10.1 Latvia Insulin Drugs & Devices Market Revenue Share, By Companies, 2025 |
10.2 Latvia Insulin Drugs & Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here